Quality Control: SOP for Monitoring Container Closure System Integrity – V 2.0
Standard Operating Procedure for Monitoring Container Closure System Integrity in Sterile Injectables
| Department |
Quality Control |
| SOP No. |
SOP/QC/168/2025 |
| Supersedes |
SOP/QC/168/2022 |
| Page No. |
Page 1 of 15 |
| Issue Date |
24/06/2025 |
| Effective Date |
26/06/2025 |
| Review Date |
24/06/2026 |
1. Purpose
This SOP defines the process for monitoring container closure system (CCS) integrity for sterile injectable products to ensure they maintain sterility and prevent contamination. The procedure supports compliance with regulatory expectations, such as those from the FDA, USP <1207>,
and Annex 1 of EU GMP.
2. Scope
This SOP applies to all sterile injectable products manufactured at the facility, including vials, ampoules, and prefilled syringes, and covers container closure integrity testing (CCIT) at development, in-process, and finished product stages.
3. Responsibilities
- QC Analyst: Executes container closure integrity tests as per approved protocols.
- QC Supervisor: Reviews test data and ensures compliance with specifications.
- QA Personnel: Verifies that results are recorded and investigated properly.
- Engineering Team: Supports testing by maintaining test instruments.
4. Accountability
The Head of Quality Control is accountable for ensuring implementation of this SOP and compliance with regulatory standards regarding CCS integrity.
5. Procedure
5.1 Types of Container Closure Integrity Tests
- Deterministic Methods: These include vacuum decay, high-voltage leak detection (HVLD), laser-based headspace analysis, and pressure decay methods. Preferred due to accuracy and reproducibility.
- Probabilistic Methods: Includes dye ingress and microbial ingress methods. Used as supportive or investigational tools.
5.2 Selection of CCS Integrity Test
- Choose appropriate test method based on container type (vial, ampoule, syringe), product sensitivity, and critical quality attributes.
- Validate the method for specificity, sensitivity, repeatability, and detection limit.
5.3 Sample Preparation
- Collect representative samples from production batches, including edge vials and stress-tested containers.
- Ensure samples are labeled with batch number, container ID, and date of sampling.
- Inspect containers for pre-test visual integrity.
5.4 Deterministic Method Procedure – Vacuum Decay
- Place sealed containers in the vacuum chamber.
- Evacuate chamber to the validated vacuum level.
- Monitor pressure changes over time; a stable pressure indicates integrity.
- Compare results to control sample readings.
5.5 Dye Ingress Test Procedure (if required)
- Submerge containers in 0.1% methylene blue solution under vacuum conditions.
- Apply vacuum for 30 minutes followed by atmospheric pressure for another 30 minutes.
- Remove containers, rinse, and inspect for dye penetration visually and/or spectrophotometrically at 660 nm.
5.6 Acceptance Criteria
- No visible dye ingress or measurable pressure change in deterministic methods.
- Acceptance criteria must align with validation protocol and regulatory guidance.
5.7 Handling of Failures
- Isolate failed samples and initiate an investigation using SOP/QC/051.
- Determine potential root causes: improper sealing, glass defects, crimping issues, etc.
- Document non-conformance and assess impact on batch disposition.
5.8 Documentation
- Record all observations, data, and instrument settings in Container Closure Integrity Test Log (Annexure-1).
- Attach instrument printouts and calibration status.
- Submit records to QA for review and archival.
5.9 Frequency of Testing
- Performed as part of routine quality control of every production batch.
- Stability samples to be tested at each scheduled interval.
- Executed post-process change, machine maintenance, or sealing system validation.
5.10 Equipment Calibration and Maintenance
- Maintain calibration schedule for CCIT equipment (Annexure-2).
- Ensure daily performance checks and quarterly maintenance.
6. Abbreviations
- CCIT: Container Closure Integrity Testing
- SOP: Standard Operating Procedure
- QA: Quality Assurance
- QC: Quality Control
- HVLD: High Voltage Leak Detection
7. Documents
- Container Closure Integrity Test Log – Annexure-1
- Equipment Calibration Record – Annexure-2
- CCIT Failure Investigation Form – Annexure-3
8. References
- USP <1207> – Container Closure Integrity Testing
- FDA Guidance for Industry – Container Closure Systems for Packaging Human Drugs and Biologics
- EU GMP Annex 1
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
|
|
|
| Designation |
QC Analyst |
QA Executive |
Head QA |
| Department |
Quality Control |
Quality Assurance |
Quality Assurance |
11. Annexures
Annexure-1: Container Closure Integrity Test Log
| Date |
Batch No. |
Container Type |
Method |
Result |
Analyst |
| 22/06/2025 |
INJ-845 |
Vial |
Vacuum Decay |
Pass |
Sunita Reddy |
Annexure-2: Equipment Calibration Record
| Instrument ID |
Model |
Last Calibration |
Next Due |
Calibrated By |
| CCIT-02 |
Micropress V900 |
15/04/2025 |
15/10/2025 |
Rajesh Kumar |
Annexure-3: CCIT Failure Investigation Form
| Date |
Batch |
Issue Observed |
Initial Assessment |
Corrective Action |
| 20/06/2025 |
INJ-842 |
Leak Detected |
Improper Sealing |
Re-trained Operators |
Revision History:
| Revision Date |
Revision No. |
Details |
Reason |
Approved By |
| 15/03/2022 |
1.0 |
Initial Release |
New Requirement |
Head QC |
| 24/06/2025 |
2.0 |
Incorporated USP <1207> and Annex 1 references |
Annual Review |
Head QA |